The University of Southampton
University of Southampton Institutional Repository

Emerging technologies for understanding platelet diversity

Emerging technologies for understanding platelet diversity
Emerging technologies for understanding platelet diversity
This review discusses our understanding of platelet diversity with implications for the roles of platelets in hemostasis and thrombosis and identifies advanced technologies set to provide new insights. We use the term diversity to capture intrasubject platelet variability that can be intrinsic or governed by the environment and lead to a heterogeneous response pattern of aggregation, clot promotion, and external communication. Using choice examples, we discuss how the use of advanced technologies can provide new insights into the underlying causes of platelet molecular, structural, and functional diversity. As sources of diversity, we discuss the proliferating megakaryocytes with different allele-specific expression patterns, the asymmetrical formation of proplatelets, changes in platelets induced by aging and priming, interplatelet heterogeneity in thrombus organization and stability, and platelet-dependent communications. We provide indications how current knowledge gaps can be addressed using promising technologies, such as next-generation sequencing, proteomic approaches, advanced imaging techniques, multicolor flow and mass cytometry, multifunctional microfluidics assays, and organ-on-a-chip platforms. We then argue how this technology base can aid in characterizing platelet populations and in identifying platelet biomarkers relevant for the treatment of cardiovascular disease.
biomarkers, cardiovascular diseases, hemostasis, megakaryocytes, platelets, thrombosis
1079-5642
540-552
Heemskerk, Johan
ad1edcd5-16b8-46a7-b6b1-fb3334e094c8
West, Jonathan
f1c2e060-16c3-44c0-af70-242a1c58b968
Heemskerk, Johan
ad1edcd5-16b8-46a7-b6b1-fb3334e094c8
West, Jonathan
f1c2e060-16c3-44c0-af70-242a1c58b968

Heemskerk, Johan and West, Jonathan (2022) Emerging technologies for understanding platelet diversity. Arteriosclerosis, Thrombosis, and Vascular Biology, 42 (5), 540-552. (doi:10.1161/ATVBAHA.121.317092).

Record type: Review

Abstract

This review discusses our understanding of platelet diversity with implications for the roles of platelets in hemostasis and thrombosis and identifies advanced technologies set to provide new insights. We use the term diversity to capture intrasubject platelet variability that can be intrinsic or governed by the environment and lead to a heterogeneous response pattern of aggregation, clot promotion, and external communication. Using choice examples, we discuss how the use of advanced technologies can provide new insights into the underlying causes of platelet molecular, structural, and functional diversity. As sources of diversity, we discuss the proliferating megakaryocytes with different allele-specific expression patterns, the asymmetrical formation of proplatelets, changes in platelets induced by aging and priming, interplatelet heterogeneity in thrombus organization and stability, and platelet-dependent communications. We provide indications how current knowledge gaps can be addressed using promising technologies, such as next-generation sequencing, proteomic approaches, advanced imaging techniques, multicolor flow and mass cytometry, multifunctional microfluidics assays, and organ-on-a-chip platforms. We then argue how this technology base can aid in characterizing platelet populations and in identifying platelet biomarkers relevant for the treatment of cardiovascular disease.

Text
ManuscriptText_Review_ATVB-2021-317092_fin - Accepted Manuscript
Download (1MB)
Text
ATVBAHA.121.317092 - Version of Record
Restricted to Repository staff only
Request a copy

More information

Accepted/In Press date: 1 March 2022
e-pub ahead of print date: 17 March 2022
Published date: 1 May 2022
Additional Information: Funding Information: This work is supported by the Landsteiner Foundation for Blood Transfusion Research Grant (No. 1711, J.W.M. Heemskerk), the British Heart Foundation (FS/13/67/30473, J. West) and the Medical Research Council (MC_PC_15078, J. West). Publisher Copyright: © 2022 Lippincott Williams and Wilkins. All rights reserved.
Keywords: biomarkers, cardiovascular diseases, hemostasis, megakaryocytes, platelets, thrombosis

Identifiers

Local EPrints ID: 457530
URI: http://eprints.soton.ac.uk/id/eprint/457530
ISSN: 1079-5642
PURE UUID: 75a9a215-315e-41b8-8d6a-fb70097a6637
ORCID for Jonathan West: ORCID iD orcid.org/0000-0002-5709-6790

Catalogue record

Date deposited: 10 Jun 2022 16:36
Last modified: 17 Mar 2024 07:18

Export record

Altmetrics

Contributors

Author: Johan Heemskerk
Author: Jonathan West ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×